The Function of Tribbles in the Pathogenesis of AML
Tribbles 在 AML 发病机制中的作用
基本信息
- 批准号:7313731
- 负责人:
- 金额:$ 33.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-01 至 2012-08-31
- 项目状态:已结题
- 来源:
- 关键词:Acute Myelocytic LeukemiaAddressBiochemicalC-terminalC57BL/6 MouseCCAAT-Enhancer-Binding ProteinsCellsComplexDataDevelopmentDiagnosisDisruptionDrosophila genusExhibitsFamily memberFundingGenesGoalsGrowthHematopoieticHematopoietic stem cellsHomeostasisHomologous GeneHumanKnockout MiceLeadLeukemic CellLinkMalignant NeoplasmsMetabolismMolecularMonitorMusMutateMutationMyelogenousOncogenesPathogenesisPatientsPhosphotransferasesPopulationPropertyProtein FamilyProteinsResearch PersonnelRoleSamplingSignal PathwaySignal TransductionSiteStructureSurveysTestingTranscriptadapter proteinbasecell typein vivoleukemiamRNA Expressionnotch proteinprogenitorprogramsprotein degradationreconstitutionresearch studytumor
项目摘要
Tribbles proteins, of which three mammalian homologues are known, are poorly characterized proteins that
have been implicated in protein degradation. They are characterized by a central non-functional kinase-like
domain. We recently identified Tribbles homologue 2 (Trib2) as a Notch-regulated transcript in leukemic cells
undergoing growth arrest. To investigate the in vivo function of Trib2, mice were reconstituted with
hematopoietic stem cells retrovirally expressing Trib2. All Trib2 reconstituted mice developed clonal acute
myelogenous leukemia (AMI) that could be serially transferred. Because Drosophila Tribbles negatively
regulates slbo, the Drosophila homologue of C/EBP, we investigated the relationship between Trib2 and
C/EBPa. We identified Trib2 in a complex with C/EBPa, which resulted in C/EBPa degradation. To
determine the relevance of our findings to human AML, a survey of Trib2 mRNA expression in human AMI
patient samples identified elevated Trib2 expression in a subset of samples. Together, our data identify Trib2
as an oncogene in the pathogenesis of AML that functions by inactivating C/EBPa. The goals of this
proposal are to determine the mechanism by which Trib2 induces C/EBPa degradation, determine the
mechanism by which Trib2 induces AML, to identify the Trib2-expressing hematopoietic progenitors that
initiate AML, and to identify genes that cooperate with Trib2 in the pathogenesis of AML. These studies
should not only lead to a better understanding of the pathogenesis of AML, but should have direct
translational utility as they will identify new targets for diagnosing and treating AML. Experiments described
in this project will greatly benefit from extensive interactions with the other Project Leaders and their projects
and will also make extensive use of the scientific cores.
Tribbles蛋白质,其中三种哺乳动物同源物是已知的,它们的特征性蛋白质很差,
与蛋白质降解有关。它们的特征是中央非功能激酶样
领域。我们最近将Tribbles同源2(Trib2)确定为白血病细胞中的缺口调节的转录本
经历增长逮捕。为了调查部落2的体内功能,将小鼠与
造血干细胞逆转录病毒表达分子2。所有Trib2重组的小鼠都会发展出克隆急性
可以连续转移的脊髓性白血病(AMI)。因为果蝇构造了负面的
调节C/EBP的果蝇同源物SLBO,我们调查了Trib2与
C/EBPA。我们在与C/EBPA的综合体中确定了Trib2,从而导致C/EBPA降解。到
确定我们的发现与人类AML的相关性,人类AMI中的Trib2 mRNA表达的调查
患者样品在样本的一部分中鉴定出升高的Trib2表达。我们的数据一起识别部落2
作为AML发病机理中的癌基因,通过失活C/EBPA起作用。目标的目标
建议是确定Trib2诱导C/EBPA降解的机制,确定
Trib2诱导AML的机制,以识别表达Trib2的造血祖细胞
启动AML,并确定与AML发病机理中与Trib2合作的基因。这些研究
不仅应该更好地理解AML的发病机理,还应有直接的
转化实用程序将确定用于诊断和治疗AML的新目标。描述的实验
在这个项目中,将大大受益于与其他项目负责人及其项目的广泛互动
并将广泛使用科学核心。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WARREN S PEAR其他文献
WARREN S PEAR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WARREN S PEAR', 18)}}的其他基金
The c-Rel Checkpoint for Immunosuppression and Immunotherapy
免疫抑制和免疫治疗的 c-Rel 检查点
- 批准号:
10338110 - 财政年份:2020
- 资助金额:
$ 33.54万 - 项目类别:
The c-Rel Checkpoint for Immunosuppression and Immunotherapy
免疫抑制和免疫治疗的 c-Rel 检查点
- 批准号:
10548886 - 财政年份:2020
- 资助金额:
$ 33.54万 - 项目类别:
Targeting the Notch:Myc axis in leukemia/lymphoma
靶向Notch:白血病/淋巴瘤中的Myc轴
- 批准号:
10322391 - 财政年份:2018
- 资助金额:
$ 33.54万 - 项目类别:
Role of Notch signaling in the Differentiation and Function of Inflammatory DCs
Notch信号在炎症DC分化和功能中的作用
- 批准号:
8386239 - 财政年份:2012
- 资助金额:
$ 33.54万 - 项目类别:
Role of Notch signaling in the Differentiation and Function of Inflammatory DCs
Notch信号在炎症DC分化和功能中的作用
- 批准号:
8499244 - 财政年份:2012
- 资助金额:
$ 33.54万 - 项目类别:
Notch Target Gene Regulation in Normal and Malignant T Cells
正常和恶性 T 细胞中的 Notch 靶基因调控
- 批准号:
8558597 - 财政年份:2006
- 资助金额:
$ 33.54万 - 项目类别:
Notch Target Gene Regulation in Normal and Malignant T Cells
正常和恶性 T 细胞中的 Notch 靶基因调控
- 批准号:
8701031 - 财政年份:2006
- 资助金额:
$ 33.54万 - 项目类别:
Notch Target Gene Regulation in Normal and Malignant T Cells
正常和恶性 T 细胞中的 Notch 靶基因调控
- 批准号:
8312783 - 财政年份:2006
- 资助金额:
$ 33.54万 - 项目类别:
Notch Target Gene Regulation in Normal and Malignant T Cells
正常和恶性 T 细胞中的 Notch 靶基因调控
- 批准号:
8895845 - 财政年份:2006
- 资助金额:
$ 33.54万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Investigating the mechanism of SHP2 and BCL2 Inhibition in Acute Myeloid Leukemia (AML)
研究急性髓系白血病 (AML) 中 SHP2 和 BCL2 抑制的机制
- 批准号:
10736325 - 财政年份:2023
- 资助金额:
$ 33.54万 - 项目类别:
Mechanisms and targeting of aberrant Gas activation in myeloid neoplasms
骨髓肿瘤中异常气体激活的机制和靶向
- 批准号:
10659809 - 财政年份:2023
- 资助金额:
$ 33.54万 - 项目类别:
Determining the Role and Targeting potential of Serine Metabolism in aggressive sub-types of Acute Myeloid Leukemia
确定丝氨酸代谢在急性髓系白血病侵袭性亚型中的作用和靶向潜力
- 批准号:
10659678 - 财政年份:2023
- 资助金额:
$ 33.54万 - 项目类别:
Molecular Pathogenesis of AF10-Rearranged Leukemias
AF10 重排白血病的分子发病机制
- 批准号:
10609055 - 财政年份:2022
- 资助金额:
$ 33.54万 - 项目类别:
The non-catalytic function of PARP2 in DNA repair and cancer therapy
PARP2在DNA修复和癌症治疗中的非催化功能
- 批准号:
10641934 - 财政年份:2022
- 资助金额:
$ 33.54万 - 项目类别: